Skip to main content
Premium Trial:

Request an Annual Quote

Organon to Use BioImage Assay Technology for Compound Profiling

NEW YORK, Sept. 7 (GenomeWeb News) - Danish biotechnology company BioImage announced today that it has signed a research agreement with Organon to profile selected lead compounds using BioImage's cell-based assay technology.


Under the terms of the agreement, Organon will utilize a series of BioImage's Redistribution assays to perform pathway profiling on selected lead compounds produced at Organon's research and development facilities in Oss, the Netherlands.


Financial terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more